OTUD6B and Miyoshi myopathy: Indeed, we show that OTUD6B inactivation nearly completely abrogates MM growth in vivo via cell cycle arrest at the G1/S checkpoint that associates with a loss of MYC expression and that high OTUD6B expression associates with an adverse outcome of the disease.